Hemophilia A Inhibitor Resources

Inhibitor development is the most severe treatment challenge that can affect anyone with hemophilia A at any time.1-3 Utilize the resources on this page to learn how the results from the SIPPET study may affect you.

HEMATOLOGIST VIDEO STORIES

Learn more about inhibitors and SIPPET from leading hematologists.

Dr. Flora Peyvandi

Hematologist

Dr. Steve Austin

Hematologist

 

DOCTOR DISCUSSION GUIDE

Start the conversation with your hematologist about your risk of developing an inhibitor. Download the Doctor Discussion Guide, which contains helpful information and questions to ask your doctor.

DOWNLOAD YOUR GUIDE

STAY CONNECTED

Sign up to receive access to the full SIPPET study, as well as updates about hemophilia, inhibitors, and the latest clinical data.

SIGN UP FOR UPDATES

 

REFERENCES

  1. Srivastava A, Brewer AK, Mauser-Bunschonten EP, et al; Treatment Guidelines Working Group. Guidelines for the Management of Hemophilia. 2nd Ed. Montreal, Canada: World Federation of Hemophilia; 2012.
  2. Hay CRM, Palmer B, Chalmers E, et al. Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom. Blood. 2011;117(23):6367-6370.
  3. Soucie JM, Miller CH, Kelly FM, et al. A study of prospective surveillance for inhibitors among persons with hemophilia in the United States. Haemophilia. 2014;20(2):230-237.
  4. Hemophilia Federation of America. What is hemophilia? Hemophilia Federation of America website. http://hemophiliafed.org/bleeding-disorders/hemophilia/. Accessed May 9, 2016.